#Breaking – TG Therapeutics makes the 2025 Deloitte Technology Fast 500™ List of America’s Fastest-Growing Companies. This recognition reflects our team’s ongoing commitment to improving the lives of patients. Details: bit.ly/4r8Q1sQ Deloitte #Fast500 #FearlessForPatients #MS #TGTX
TG Therapeutics, Inc.
Biotechnology Research
Morrisville, North Carolina 41,924 followers
TG is a biopharmaceutical company focused on the development of novel treatments for B-cell diseases.
About us
TG Therapeutics is a fully integrated, commercial stage, biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline including several investigational medicines, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI® (ublituximab-xiiy) for the treatment of adult patients with relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features. For more information, visit www.tgtherapeutics.com, and follow us on X (formerly Twitter) @TGTherapeutics and on LinkedIn. BRIUMVI® is a registered trademark of TG Therapeutics, Inc.
- Website
-
http://www.tgtherapeutics.com/
External link for TG Therapeutics, Inc.
- Industry
- Biotechnology Research
- Company size
- 201-500 employees
- Headquarters
- Morrisville, North Carolina
- Type
- Public Company
- Founded
- 2011
- Specialties
- Biotechnology, multiple sclerosis, b-cell diseases, ublituximab, subcutaneous, RMS, and Azer-Cel
Locations
-
Primary
Get directions
3020 Carrington Mill Blvd
Suite 475
Morrisville, North Carolina 27560, US
-
Get directions
New York, NY 10014, US
Employees at TG Therapeutics, Inc.
Updates
-
#JoinUs #Today for the Fireside Chat with TG CEO Mike Weiss at the TD Cowen Immunology & Inflammation Summit. Wed., Nov. 12th at 10:00AM ET - Watch: https://lnkd.in/eC6nRGS #TGTX #FearlessForPatients
-
-
#SaveTheDate – Join the Fireside Chat with TG's CEO Mike Weiss at the TD Cowen Immunology & Inflammation Summit. Webcast on Wed., Nov. 12th at 10:00AM ET at https://lnkd.in/eC6nRGS #TGTX #FearlessForPatients
-
-
We’re honored to share that TG Therapeutics has been named one of BioSpace Top 10 Best Places to Work for 2026! This recognition celebrates our incredible team, who bring passion and purpose to everything we do. At TG, we’re united by a mission to improve the lives of patients, and that mission shines through in our innovative, collaborative, and inspiring culture. #TGTX #FearlessForPatients
-
-
#TGTX Q3 2025 Financial Results have been released! Details: bit.ly/3JpFbOl - Join our #Earnings call this morning, Nov. 3rd at 8:30AM ET. Dial in: 1-877-407-8029 (US), 1-201-689-8029 (Ex-US) Title: TG Q3 2025 – Webcast at: https://lnkd.in/eguXMYM #FearlessForPatients
-
-
#TGTX will host a Q3 2025 Earnings Call on Monday, November 3rd, 2025 @ 8:30AM ET. To Join our Call - Dial in: 1-877-407-8029 (US), 1-201-689-8029 (Ex-US) Title: TG Q3 2025 - Webcast will be available at: https://lnkd.in/eguXMYM #FearlessForPatients #Earnings
-
-
#BreakingNews – TG completes enrollment in the randomized Phase 3 ENHANCE Trial evaluating a streamlined IV dosing schedule for adults with relapsing forms of #MS. Details: bit.ly/4hw3JBC #FearlessForPatients #TGTX
-
-
#TGTX shared 3 presentations today @ #ECTRIMS2025 including new data showing approximately 90% of RMS patients are free from disability progression after 6 yrs on therapy! Learn more: bit.ly/4nKgieu - Visit our TG/Neuraxpharm Booth A04 for #BOOTHTALKS 9/25 10:55 & 13:00 CEST
-
-
Please #JoinUs - #BOOTHTALKS at #ECTRIMS2025 – Wed & Thurs (10:55 & 13:00 CEST) at our TG/NRX Booth at A04. Meet with leading #MS experts to discuss their clinical experience with our therapy for #RMS and gather useful information for your patients. #FearlessForPatients #TGTX
-
-
Abstracts are Live! #ECTRIMS2025 Barcelona, Spain Sept. 24-26. #TGTX will share 3 presentations highlighting data in #RMS. Abstracts & Learn More: bit.ly/3HPtorW Please visit our TG Booth A04 and our TG/NRX Business Lounge on Level 2 #MS #FearlessForPatients
-